Finasteride for Post Finasteride Syndrome
Whether Post-Finasteride Syndrome is a real, distinct condition remains unverified and genuinely disputed: persistent symptoms are reported and carry a regulatory safety warning, but the highest-quality evidence has not confirmed PFS as a discrete syndrome with a proven causal link. Note that finasteride is the suspected cause here, not a treatment.
Why this grade7-layer evidence engine
The grade reflects a structural split in the evidence rather than a clear answer. A large meta-analysis (PMID 34747724, n=25,696) found 5-alpha-reductase inhibitors significantly raised sexual and overall adverse effects during treatment (RR 1.87), but these were on-treatment events, not proof that symptoms persist after the drug is stopped. A 2025 systematic review (PMID 39953145) argues the reported symptoms deserve recognition and prospective registries, though it is advocacy-linked with undisclosed funding.
Against a distinct, persistent syndrome, the strongest causal data do not support it. A 2019 meta-analysis (PMID 31190484, n=209,940) found depression risk was not statistically significant, and a 2025 UK Biobank cohort plus Mendelian randomization study (PMID 41330881, n=388,894) found no causal link between finasteride and depression or suicide. A 2022 literature review (PMID 35983808, n=87,887) concluded finasteride is only rarely associated with such effects, noting the field is skewed by specialty attention.
Regulators and clinics are split, which drives the disputed status. The US FDA label acknowledges sexual dysfunction that continued after discontinuation, and WHO pharmacovigilance and the UK NHS note the safety signal. But mainstream bodies stop short of endorsing PFS as a formal diagnosis, and Mayo Clinic states side effects resolved in those who stopped. So a genuine safety signal exists and consumers should be informed, but PFS as a verified, criteria-based syndrome is not established.
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditable▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.418
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高階證據未達主導 (1 positive vs 1 negative)，由 raw_score 決定
- tier_strict_requirement_check — | C→U 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
- detect_disputes — 偵測到 1 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status